Luigi Grasso
Fondateur chez Navrogen, Inc.
Postes actifs de Luigi Grasso
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Navrogen, Inc.
 Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | 01/01/2017 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2017 | - | |
| Fondateur | 01/01/2017 | - |
Historique de carrière de Luigi Grasso
Anciens postes connus de Luigi Grasso
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Directeur Technique/Scientifique/R&D | 01/05/2000 | 01/04/2018 |
| Fondateur | 23/02/2011 | 01/04/2018 |
Formation de Luigi Grasso
| University of Catania | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Italie | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Commercial Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Morphotek, Inc.
Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
Navrogen, Inc.
Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Bourse
- Insiders
- Luigi Grasso
- Expérience
